Victor Minton and Rudy Rodriguez at AAD's Research Triangle Park laboratory
Bringing important new diagnostic technology to market
That is the passion that unites AAD founders and management. After decades of success developing significant new human diagnostic devices (like the world’s first random access chemistry analyzer, the QBC Hematology System, the QBC Malaria Detection System and many more), AAD founders started the company in 2001.
Our vision? To bring the power of rapid diagnostics on farm to benefit the under-served animal agriculture market.
By providing vets and producers with valuable new information to monitor animals’ health without waiting days for results, AAD can improve profits for the industry and protect animal health and welfare, while enhancing consumer confidence in the food source.
To this end, AAD is creating its own intellectual property as well as developing and commercializing exclusively licensed proprietary technology. We are now selling our first product – the QuickSmear™ rapid differential slide to speed and simplify production animal research using differential cell counts. We are also in the early stages of commercializing our first farm-based diagnostic, the SCC+™ System for early detection of mastitis. Development of the base technology was jointly funded by healthcare technology leaders Becton Dickinson and Battelle, creating the powerful intellectual property portfolio AAD has licensed. AAD’s founder Rudy Rodriguez is a co-inventor of some of the technology improvements. While our first products are designed to stem losses from mastitis, look for this platform technology and others to make many more contributions to protect and serve animal agriculture across species in the future.